March 16, 2017

Government Directs Hospitals To Issue Detailed Bills To Patients

Billing Statement

The government has directed hospitals to issue detailed bills to patients, specifically and separately mentioning the cost of coronary stents. According to a notification issued by the National Pharmaceuticals Pricing Authority (NPPA - a government regulatory agency that controls the prices of pharmaceutical drugs in India), hospitals have also been told to mention the brand name of the manufacturer and importer, batch number, and other details.

Minister of State for Chemical and Fertilisers Mansukh Mandaviya said, “The non-compliance thereof will be treated as a deliberate distortion of evidence along with charges of overpricing, inviting prosecution under the Essential Commodities Act.” Mandaviya then said, “The government is committed to making available stents at affordable prices and hospitals have to fall in line else stern actions would be initiated against whom complaints of overcharging have been received.”

Mandaviya further added that “The government, through NPPA, is closely monitoring the situation and has alerted the State Governments and State Drugs Controllers to monitor the availability of stents. The industry has also been told that all manufactures and importers are under legal obligation to maintain smooth production and supply of coronary stents of all brands that were available in the country before price cap."

Related Post

latest News

  • Take urgent steps to contain NPAs: Parliamentary committee

    A Parliamentary panel has asked the government to take urgent steps to reduce volume of stressed assets in the system and strengthen vigilance mechani...

    Read More
  • U.S. Supreme Court takes up dispute over power plant in India

    On May 21, the US Supreme Court said it will examine a complaint by Indian villagers who say they are suffering from pollution caused by a coal power ...

    Read More
  • CCI brings-out Policy Note on ‘Making Markets Work for Affordable Healthcare’

    Over the nine years of enforcement of the Competition Act, 2002 (the Act), the Competition Commission of India (‘the Commission’) has received 52 ...

    Read More